Blocking the ATR‐SerRS‐VEGFA pathway targets angiogenesis for UV‐induced cutaneous squamous cell carcinoma
Molecular Carcinogenesis · 2024
DOI: 10.1002/mc.23716 ↗At a glance
Journal article in Molecular Carcinogenesis, 2024. Written by Hongyan Lu and 7 co-authors. Institution: Department of Dermatology and Venereology, Nanfang Hospital, Southern Medical University, Guangzhou, China. Major MEDLINE topics: Vascular Endothelial Growth Factor A, Skin Neoplasms, Ultraviolet Rays, Carcinoma, Squamous Cell. Cited 2 times so far (Crossref); 46 references. Funded by: National Natural Science Foundation of China, The President Foundation of Nanfang Hospital, Southern Medical University, Guangzhou Science and Technology Planning Project.
Abstract (original language)
Cutaneous squamous cell carcinoma (cSCC) is the second most prevalent form of skin cancer, with an escalating incidence rate and a notable potential (up to 5%) for metastasis. Ultraviolet radiation (UVA and UVB) exposure is the primary risk factor for cSCC carcinogenesis, with literature suggesting ultraviolet radiation (UVR) promotes vascular endothelial growth factor A (VEGFA) expression. This study aims to investigate UVR‐induced upregulation of VEGFA and explore combination therapeutic strategies. The skin squamous cell carcinoma cell line A431 was exposed to specific durations of ultraviolet radiation. The effect of emodin on ATR/SerRS/VEGFA pathway was observed. The cell masses were also transplanted subcutaneously into mice ( n = 8). ATR inhibitor combined with emodin was used to observe the growth and angiogenesis of the xenografts. The results showed that UV treatment significantly enhanced the phosphorylation of SerRS and the expression level of VEGFA in A431 cells ( p < 0.05). Treatment with emodin significantly inhibited this expression ( p < 0.05), and the combination of emodin and ATR inhibitor further enhanced the inhibitory effect ( p < 0.05). This phenomenon was further confirmed in the xenograft model, which showed that the combination of ATR inhibitor and emodin significantly inhibited the expression of VEGFA to inhibit angiogenesis ( p < 0.05), thus showing an inhibitory effect on cSCC. This study innovatively reveals the molecular mechanism of UV‐induced angiogenesis in cSCC and confirms SerRS as a novel target to inhibit cSCC angiogenesis and progression in vitro and in vivo studies.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Dermatology and Venereology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- Department of Plastic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.
ORCID profiles: Hongyan Lu
Funding
- National Natural Science Foundation of China
- The President Foundation of Nanfang Hospital, Southern Medical University
- Guangzhou Science and Technology Planning Project
- GuangDong Basic and Applied Basic Research Foundation
- The 73rd Batch of General Projects of China Postdoctoral Science Foundation
- Natural Science Foundation of Guangdong Province
Cite
APA
Lu, H., Peng, Z., Zheng, Z., Li, C., Wang, Y., Liang, L., Chen, Y., & Zeng, K. (2024). Blocking the ATR‐SerRS‐VEGFA pathway targets angiogenesis for UV‐induced cutaneous squamous cell carcinoma. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23716
Vancouver
Lu H, Peng Z, Zheng Z, Li C, Wang Y, Liang L, et al. Blocking the ATR‐SerRS‐VEGFA pathway targets angiogenesis for UV‐induced cutaneous squamous cell carcinoma. Molecular Carcinogenesis. 2024. doi:10.1002/mc.23716
BibTeX
@article{Lu2024,
author = {Lu, Hongyan and Peng, Zhangsong and Zheng, Zhaohui and Li, Changxing and Wang, Youyi and Liang, Liuping and Chen, Yuxiang and Zeng, Kang},
title = {Blocking the ATR‐SerRS‐VEGFA pathway targets angiogenesis for UV‐induced cutaneous squamous cell carcinoma},
journal = {Molecular Carcinogenesis},
year = {2024},
doi = {10.1002/mc.23716}
}
EUVIMED